[Form 4] Hims & Hers Health, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Hims & Hers director Manuel Anja was granted 3,656 Restricted Stock Units (RSUs) on 08/06/2025, each representing a contingent right to one share of Class A common stock. The filing reports 3,656 shares beneficially owned following the grant and lists the ownership form as Direct (D). Vesting requires continuous service and occurs at the earlier of the company27s 2026 annual meeting or June 15, 2026, meaning the award will convert to shares only if service continues until that event. The grant specifies a $0 price for the RSUs and does not include performance-based conditions in the explanation provided.

Insights

Financial Analyst

TL;DR: Routine director RSU grant; direct ownership and clear vesting, limited immediate market impact.

The Form 4 discloses a grant of 3,656 RSUs to director Manuel Anja, reported as directly beneficially owned following the award. The RSUs convert one-for-one to Class A common stock upon vesting, which is tied solely to continuous service and timing (earlier of the 2026 annual meeting or June 15, 2026). The filing does not state outstanding share count or percentage dilution, so materiality relative to the capital structure cannot be determined from this document alone. No cash purchase or sale was reported.

Corporate Governance Expert

TL;DR: Compensation-focused grant that aligns director with shareholders via time-based vesting; non-performance-based award.

The disclosed award is a time-vested RSU grant with a clearly defined vesting trigger tied to continued service through a company event or date. The Form 4 shows direct beneficial ownership and a $0 stated price for the RSUs, and the explanation contains no performance metrics or additional conditions. From a governance perspective, this appears to be a retention/compensation mechanism rather than an incentive tied to operational milestones, based solely on the information provided.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Manuel Anja

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CA 94123

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/06/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	08/06/2025		A		3,656		(1)	(1)	Class A Common Stock	3,656	$0	3,656	D

Explanation of Responses:

1. The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. Subject to continuous service, the RSUs will vest on the earlier of (a) the date of the 2026 annual meeting of stockholders or (b) June 15, 2026.

Remarks:

	/s/ Alexandra Cotter Wilkins, Attorney-in-Fact	08/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Manuel Anja receive in the HIMS Form 4?

The filing shows a grant of 3,656 Restricted Stock Units (RSUs), each representing a contingent right to one share of Class A common stock.

When do the RSUs granted to Manuel Anja vest?

The RSUs vest upon continuous service at the earlier of the 2026 annual meeting or June 15, 2026.

What ownership is reported after the RSU grant in the Form 4?

The Form 4 reports 3,656 shares beneficially owned following the grant, with ownership listed as Direct (D).

Was there a purchase or sale price reported for the RSUs?

The RSUs are reported with a $0 price in the filing; they represent contingent rights to future shares upon vesting.

Does the Form 4 indicate performance conditions for the RSU grant?

No performance conditions are disclosed; the explanation describes only time-based vesting tied to continuous service and timing events.